| Literature DB >> 36242608 |
Koji Nukuto1, Takehiko Matsushita2, Kohei Kamada1, Kyohei Nishida1, Kanto Nagai1, Noriyuki Kanzaki1, Yuichi Hoshino1, Tomoyuki Matsumoto1, Takahiro Niikura1, Ryosuke Kuroda1.
Abstract
Medial meniscus posterior root tears (MMPRT) are often associated with osteoarthritis (OA) progression and subchondral bone insufficiency fractures. This study aimed to develop the first MMPRT mouse model. The MMPRT model was created by sectioning the medial meniscus posterior root of 12-week-old CL57BL/6J male mice under stereomicroscopic observation. The sham operation and the destabilization of the medial meniscus (DMM) model groups were also created. OA progression and subchondral bone changes were evaluated histologically using the Osteoarthritis Research Society International (OARSI) subchondral bone scoring system at 2, 4, 8, and 12 weeks after surgery. Microcomputed tomography (µCT) was performed to evaluate the presence of insufficient fractures. OA progression and medial meniscus extrusion were observed in the MMPRT and DMM models 12 weeks after surgery. OA progressed in both models during the time course, without a significant difference in the OARSI score between the two groups. The subchondral bone score was significantly higher at 12 weeks than at 2 and 4 weeks in the MMPRT group, while no significant difference was found between the two groups. In the µCT analysis, destruction of the medial tibial plateau was observed in 4/40 knees, while none were observed in the DMM group. Of the four knees, destruction of the medial femoral condyle was also observed in three knees. Characteristic pathological changes were observed in the mouse MMPRT model. The mouse MMPRT model may be useful for investigating pathological changes after MMPRT.Entities:
Keywords: Medial meniscus posterior root tear; Osteoarthritis; Osteoarthritis model in mice; Subchondral bone insufficiency fracture
Year: 2022 PMID: 36242608 DOI: 10.1007/s00223-022-01028-1
Source DB: PubMed Journal: Calcif Tissue Int ISSN: 0171-967X Impact factor: 4.000